EcoDrugPlus

Tyrosine Kinase With Immunoglobulin Like And Egf Like Domains 1

Ensembl ID : ENSNGAG00000000121
Gene Symbol: TIE1
3 Cross references
203 Possible Orthologues:

Vascular Endothelial Growth Factor A

Ensembl ID : ENSNGAG00000018293
Gene Symbol: VEGFA
1 Cross references
253 Possible Orthologues:

Vitamin D Receptor

Ensembl ID : ENSNGAG00000011996
Gene Symbol: VDR
2 Cross references
458 Possible Orthologues:

Vitamin K Epoxide Reductase Complex Subunit 1

Ensembl ID : ENSNGAG00000017764
Gene Symbol: VKORC1
3 Cross references
189 Possible Orthologues:

Xanthine Dehydrogenase

Ensembl ID : ENSNGAG00000016340
Gene Symbol: XDH
3 Cross references
211 Possible Orthologues:

Ensembl ID : ENSNGAG00000015117
Gene Symbol: -
Cross references: -
95 Possible Orthologues:

Ensembl ID : ENSNGAG00000012827
Gene Symbol: -
Cross references: -
222 Possible Orthologues:

Ensembl ID : ENSNGAG00000016209
Gene Symbol: -
Cross references: -
205 Possible Orthologues:

Ensembl ID : ENSNGAG00000021067
Gene Symbol: -
Cross references: -
134 Possible Orthologues:

Ensembl ID : ENSNGAG00000014438
Gene Symbol: -
Cross references: -
251 Possible Orthologues:

Ensembl ID : ENSNGAG00000020002
Gene Symbol: -
Cross references: -
171 Possible Orthologues:

Ensembl ID : ENSNGAG00000017632
Gene Symbol: -
Cross references: -
173 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).